Literature DB >> 19094818

Can metronidazole still be used for treatment of Clostridium difficile infections?

Haihui Huang1, Carl Erik Nord.   

Abstract

Entities:  

Year:  2009        PMID: 19094818     DOI: 10.1007/s11908-009-0001-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  38 in total

1.  Prevalence of nim genes in anaerobic/facultative anaerobic bacteria isolated in South Africa.

Authors:  M M Lubbe; K Stanley; L J Chalkley
Journal:  FEMS Microbiol Lett       Date:  1999-03-01       Impact factor: 2.742

2.  High levels of resistance to fluoroquinolones among Clostridium difficile isolates in a Spanish hospital.

Authors:  Mar Sánchez-Somolinos; Luis Alcalá; Teresa Peláez; Mercedes Marín; Adoración Martín; Pilar Catalán; Emilio Bouza
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

3.  Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.

Authors:  S S Wong; P C Woo; W K Luk; K Y Yuen
Journal:  Diagn Microbiol Infect Dis       Date:  1999-05       Impact factor: 2.803

Review 4.  Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Authors:  E Bricker; R Garg; R Nelson; A Loza; T Novak; J Hansen
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

5.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.

Authors:  Daniel M Musher; Nancy Logan; Vaibhav Mehendiratta; Nicolas A Melgarejo; Sagar Garud; Richard J Hamill
Journal:  J Antimicrob Chemother       Date:  2007-03-02       Impact factor: 5.790

7.  Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly.

Authors:  Sari Tal; Alexander Gurevich; Vladimir Guller; Irina Gurevich; David Berger; Shmuel Levi
Journal:  Scand J Infect Dis       Date:  2002

8.  Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants.

Authors:  Micaela Gal; J S Brazier
Journal:  J Antimicrob Chemother       Date:  2004-06-09       Impact factor: 5.790

9.  Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.

Authors:  Wafa N Al-Nassir; Ajay K Sethi; Michelle M Nerandzic; Greg S Bobulsky; Robin L P Jump; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

10.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

View more
  2 in total

Review 1.  Anaerobic infections: update on treatment considerations.

Authors:  Elisabeth Nagy
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

Review 2.  Clostridium difficile infection in the twenty-first century.

Authors:  Chandrabali Ghose
Journal:  Emerg Microbes Infect       Date:  2013-09-18       Impact factor: 7.163

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.